By Ben Glickman
YS Biopharma said a fake press release distributed under the company’s name called for an extraordinary general meeting of shareholders.
The Gaithersburg, Md.-based company said Wednesday that an unauthorized release had called for an extraordinary general meeting on Dec. 28, but that shareholders should disregard the notice, as the meeting is “not sanctioned by the company and attendance is unnecessary.”
The company encouraged stakeholders to seek accurate information from the company’s official communication channel.
YS also clarified that Yi Zhang was not chairperson of the board and does not have authority to call a general meeting.
PR Newswire sent out a notice on Wednesday instructing subscribers to disregard a press release from YS Biopharma issued earlier that day, as it contained “erroneous information.”
Write to Ben Glickman at [email protected]
Read the full article here
